Insights
The needs of healthcare consumers are ever evolving, as are the methods and technologies used to engage them effectively. Our passion for, and deep roots in these efforts are reflected in the information we share here.
Reach out to learn more partnerships@em.reverba.com
Reverba selected as a Gold Winner in the 2024 TITAN Business Awards, which recognize the achievements, leadership and innovation of organizations worldwide that are driving industries forward –
Seattle, WA – November 15, 2024 – Reverba, a global health engagement company specializing in innovative and compliant patient engagement and medical communication solutions for biopharmaceutical companies, today announced that the company has been selected as a Gold Award winner in the 2024 TITAN Business Awards. Reverba was recognized in the Business-to-Business category for ReverbaLINK®,…
Read More
Patient Engagement Throughout the Product Lifecycle
Key considerations for effective patient engagement throughout the product lifecycle and clinical trials, and how to leverage this engagement as the industry moves forward Watch this thought-provoking video discussion as our CEO, Cheryl Lubbert shares her insights with Pharmaceutical Executive on best practices for engaging patients from pre-clinical through commercialization stages and beyond. Watch here https://bit.ly/4eXNIm6 or read the…
Read More
Cheryl Lubbert, CEO named in 30 Most Inspiring Leaders to Watch 2024 by The Silicon Review
An innovator ensuring patient voices are heard, driving meaningful innovations in biotech and healthcare through engagement and data. By The Silicon Review Reverba, Co-Founded by Cheryl Lubbert, is a pioneering company dedicated to integrating patient voices into the heart of healthcare innovation. Previously known as Health Perspectives Group, Reverba emerged from Lubbert’s vision of closing…
Read More
Reverba Announces Appointment of Scott Wolf as Chief Growth Officer
Experienced expert in scaling business and growing revenue will expand Reverba’s global market reach. Seattle, WA – Reverba, a global health engagement company specializing in innovative and compliant patient engagement and medical communication solutions for biopharmaceutical companies, today announced the appointment of Scott Wolf as the company’s Chief Growth Officer (CGO). In his new role,…
Read More
Top Takeaways from DPHARM 2024: Using Engagement to Tackle Clinical Trial Challenges for Patients and Sites
The annual DPHARM® conference is always a hub of groundbreaking discussions, gathering leaders across the biopharma industry to explore ways to improve the clinical trial process, reduce patient and physician burden, and drive greater inclusivity, access and efficiencies. The Reverba team was out in full force at this year’s conference to exchange ideas, discuss challenges,…
Read More
Reverba named top 10 Patient Engagement Solution Provider of 2024
Setting the Trend with Innovative Patient Engagement Strategies By: Cheryl Lubbert, CEO, published in Medhealth Review In the healthcare landscape, patient engagement has become a critical foundational element for achieving positive health outcomes, and a range of healthcare and pharmaceutical companies turn to this important approach to incorporate the patient voice throughout their programs and…
Read More
Building Connections for Clinical Trials: How Patients Can Improve Trial Enrollment & Engagement – Part 3
Part 3 of 3: Engaging patients before, during and after the clinical process This blog is part 3 of a series on the impact and benefits of patient involvement with the clinical trial process – patient willingness to participate in trials, what they can contribute beyond their role as study participant and how to most…
Read More
Building Connections for Clinical Trials: How Patients Can Improve Trial Enrollment & Engagement – Part 2
By: Clinical Partnerships Team Part 2 of 3: How patients can improve clinical trial design This blog is part 2 of a series on the impact and benefits of patient involvement with the clinical trial process – patient willingness to participate in trials, what they can contribute beyond their role as a study participant and…
Read More
Building Connections for Clinical Trials: How Patients Can Improve Trial Enrollment & Engagement – Part 1
By: Clinical Partnerships Team Once a promising new drug candidate reaches the clinic, many R&D challenges have already been overcome. But the goal of the clinical trial process to produce quality data brings a new set of challenges. The process of enrolling patients—finding not only the number of patients needed to participate, but the right…
Read More
Podcast: Patient engagement throughout the product life cycle
Take a listen to this thought-provoking podcast as our CEO, Cheryl Lubbert shares her insights with pharmaphorum on best practices for engaging patients from pre-clinical through commercialization stages and beyond. Listen here https://lnkd.in/g7xyVECd In the podcast, Reverba CEO Cheryl Lubbert joins host Jonah Comstock to walk through the steps of the product life cycle and…
Read More
Rainbow flags are flying: Three ways to include diversity in your clinical program
By: Clinical Trial Partnerships If you are planning clinical trials, Pride Month is the perfect time to take a close look at your diversity initiatives to be sure they encompass inclusion of LGBTQ+ patients in clinical trials. This is an important goal that carries unique challenges. Recent studies reveal that LGBTQ+ community members experience healthcare…
Read More
Unicorns do Exist: Finding the Right Patients for Clinical Trials
By: Clinical Partnerships Team It’s no secret that patient recruitment is critical for a successful clinical trial. From first patient/first dose to data lock, everything rests on enrolling (and retaining) enough participants. Otherwise, costs go up, and so does demand on resources. Treatments take longer to get to market or—worse yet—the trial gets cancelled. But…
Read More
How to Make Your Clinical Trial the Trial of Choice: When You Want to Get to Market Faster, Meeting Every Milestone Matters.
By: Reverba Clinical Partnerships Team From first patient/first dose to data lock, everything depends on recruiting and retaining clinical trial participants. That can be quite challenging. A 2022 editorial in Clinical Trials Arena noted that the biggest reason for trial termination is low accrual rates which have accounted for 25.4% of all terminated trials. The good…
Read More
Clinical Trials Day: May 20th
Today is Clinical Trials Day –a day where clinical trial awareness is raised and we honor clinical research professionals across the globe. In tribute, we are pleased to showcase a recent article in MedCityNews where a Health Stories Project® research study was cited, revealing that 97% of patients believe that their voice is key for…
Read MoreReverba Completes Acquisition of Six Degrees Worldwide to Unite Science and the Patient Voice to Advance Healthcare
SEATTLE, WA – Reverba, renowned for its innovative patient engagement solutions for biopharmaceutical companies, today announced the acquisition of Six Degrees Worldwide Inc., a leader in medical communications within the same industry. The acquisition is poised to help Reverba and its clients continue to bridge the gap between science and real-life patient experiences. Reverba’s acquisition will…
Read More
HBA Rising Star: Crystal Anderson
By: Cheryl Lubbert We’re thrilled to announce the Healthcare Businesswomen’s Association (HBA) recently named Crystal Anderson, MPH, VP, Client Partner Lead as one of its 2024 Rising Stars. Crystal joins a noteworthy group of healthcare professionals recognized for their leadership and significant contributions to their organization – all in the first 15 to 20 years…
Read More
Treatments for All: The Importance of Diversity in Clinical Trial Enrollment
By: Scott Lerman, VP, Partnerships Lead We start, as many stories do, with a personal anecdote. I love this photo. It’s of my grandmother and my father, taken at my Bar Mitzvah more than 40 years ago. Our family lore ultimately deemed this day my grandmother’s “last good day.” She passed away a little less…
Read More
Knock Down Internal Silos and Add More Value To The Patient Voice
By: Jean McCoy EVP Reverba Partnerships When it comes to listening to patients, clinical and consumer marketing tends to remain in separate silos. But incorporating the patient voice can make a positive impact at every point from pre-clinical development through commercialization and post-marketing. Doing so can help companies align their goals and programs with patients’…
Read More
“The secret to successful patient influencer marketing? Authenticity”
Published in pharmaphorum By: Cheryl Lubbert, Co-Founder and CEO Reverba It may not be as straightforward as it is in the realms of fast fashion or tourism, but influencer marketing, especially on social media, is still an attractive avenue in the pharma world. Pharma companies strive to connect with patients, and what better way to…
Read More
Reverba: Amplifying Patient Voices In Healthcare
Published in Healthcare Business Review By: Cheryl Lubbert, Co-Founder and CEO While patient-focused drug development (PFDD) is the aspirational goal for every pharmaceutical company, achieving it is often more complex than anticipated. The main reason is many pharma companies view PFDD as a technological maneuver when rolling out patient engagement initiatives. Fully adopting it necessitates a…
Read More
Reverba CEO and Co-Founder Cheryl Lubbert Wins 2023 Silver Stevie® Award for Women in Business
– Awards recognize female entrepreneurs, executives and employees who are making positive contributions to their workplace and to the greater community – SEATTLE, WA, Nov. 13, 2023 – Reverba, a leading global patient engagement company, today announced that Cheryl Lubbert, Chief Executive Officer, has won the Silver Stevie® Award for Women in Business in the Mentor of the Year…
Read More
Survey: 3 Surprising Things BioPharma Can Learn about Patients’ Perceptions
By Jean McCoy Reverba EVP, Partnerships Perception is reality, as the saying goes. But sometimes, we can be too entrenched in our daily routine, entrenched in our field, and we can miss key factors that could change the way we think about what we do day to day. We recently conducted two parallel surveys that,…
Read More
Reverba Co-Founder and CEO Cheryl Lubbert named Women Leaders in Business Gold Globee® Winner
– Awards recognize individuals and women-led organizations who have demonstrated extraordinary dedication and innovation – SEATTLE – October 18, 2023 – Reverba, a leading global patient engagement company, today announced that Cheryl Lubbert, Co-Founder and CEO, has been recognized as a Women Leaders in Business Gold Globee® Winner, for her contributions and role in creating…
Read More
Authenticity In An Automated World: Surprising Guidance From Healthcare
Published in Forbes By: Cheryl Lubbert, Forbes Councils Member When faced with online customer service “agents” who don’t have real answers or solutions for specific problems, email responses that don’t sound quite human and videos that could be deceptive altered deepfakes, consumers increasingly have questions about what is real. In a world of growing automation…
Read More
Embrace the Rainbow: Three Tips to Make DEI Foundational In Your Clinical Program
By: Jean McCoy Diversity in clinical trials is a hot-button topic, with attention and programs ranging from legislation (both proposed and passed) to industry conference panels and required continuing education for healthcare professionals. While these initiatives usually address “underrepresented communities,” in practice, they often refer to increasing participation among racial and ethnic groups. During Pride…
Read More
Reverba Maintains Commitment to Patient Data Security and Privacy with Ongoing SOC 2®, Type II Certification
SOC 2 certification aligns Reverba with world-class organizations achieving the highest level of security and compliance for data management for service organizations – SEATTLE – April 20, 2023 – Reverba, a leading global patient engagement company, announces that it has successfully reaffirmed the Service Organization Control (SOC) 2, Type II certification for 2023, completing this important…
Read More
The Patient Voice: Industry and Advocates Speak in Harmony
By: Jean McCoy A generation ago, HIV/AIDS patients had to “Act Up” to be heard. A recent virtual summit shows how much has changed since the days of that pioneering patient advocacy group. At the Global Innovation in Patient Advocacy conference, one theme echoed throughout multiple presentations by patient advocates and industry representatives alike: it’s important to…
Read More
How Can We Have More Successful Rare Disease Trials?
By: Reverba Clinical Partnerships Team More than 300 million people around the world live with a rare disease—that is, a condition that affects fewer than 1 in 2,000. Although each of these estimated 5,000 to 7,000 or more rare diseases affects a relatively small number of individuals, the impact on those patients’ lives is significant.…
Read More
Be the Trial of Choice: patient insights on how to establish trust, elevate the experience, and increase diversity
By: Reverba Clinical Partnerships Team We have all made New Year’s resolutions – some we keep, and some never come to fruition. What are your goals as an organization? You have an investigative product that can impact lives globally, but do you have the right plan and partners in place to reach your patients and…
Read More
Patient Engagement: What Matters Most in 2023
By: Cheryl Lubbert Think about 2022 – what stands out to you the most? For me, it’s how often we heard that things were “returning to normal” after two years of global pandemic. Yes, many events were in-person once again and lots of companies began pushing for people to return to the office, but have…
Read MoreReverba Celebrates 20 Years of Amplifying Patient Voices
– 20th Anniversary demonstrates Reverba has the staying power and adaptability to continue leading the way in patient engagement solutions for life sciences companies – SEATTLE – October 10, 2022 – Reverba, a leading global patient engagement company, announces the celebration of its 20th Anniversary. This marks two decades of empowering people to share their…
Read More
It’s Our Anniversary: 20 Years, 20 Reasons to Believe
By: Cheryl Lubbert Today, we turn 20. Sixteen may be sweet, but twenty means so much more when you’re talking about the lifetime of a company. In an age of flash-in-the-pan startups, building a company that doesn’t just last – but one that grows, thrives, and defines the industry it’s a part of – is…
Read More
HBA Rising Star: Stephanie Hayes
By: Cheryl Lubbert As a pioneer in patient engagement, Reverba wouldn’t be where it is today without a talented team of individuals in roles spanning the organization. Every so often, though, someone truly sets themselves apart as the kind of transformational leader that attracts the recognition of the healthcare industry at large. Stephanie Hayes is…
Read MoreHealth Perspectives Group becomes Reverba
Entering the company’s 20th year, this new chapter represents the next level of transformativetech-enabled patient engagement for the biopharmaceutical industry – SEATTLE – November 10, 2021 – Health Perspectives Group, a leader in patient engagement, today announced its name change to Reverba. The name change reflects the firm’s evolution into a new type of global…
Read More